8-K Hepion Pharmaceuticals, Inc. 2026-09-08: filing_items
| Value | {"items": {"1.01": "Entry into a Material Definitive Agreement", "2.03": "Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant", "3.02": "Unregistered Sales of Equity Securities", "9.01": "Financial Statements and Exhibits"}, "value": "1.01,2.03,3.02,9.01"} |
|---|---|
| Period | (as of 2026-09-08) |
| Status | current |
| Entity | 8-K Hepion Pharmaceuticals, Inc. 2026-09-08 |
Provenance
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/0001493152-26-041801-in
Retrieved: 2026-09-08T23:35:07.195781+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/2ed03fe9-d214-4623-b4de-48b8db0a3a92
Source: SEC EDGAR 8-K — amtlicher Ereignisstrom (Current Reports) (Public Domain (17 U.S.C. §105))
Reference: https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/0001493152-26-041801-in
Retrieved: 2026-09-08T23:35:07.195781+02:00
Raw response sha256:
74510ac5b37367b0c7d9453e671bd8da…Cite as: FACTANKER, https://factanker.com/fact/2ed03fe9-d214-4623-b4de-48b8db0a3a92
History
- no predecessors — first report